What is the projected market valuation for the China piriformis syndrome market in 2035?

The projected market valuation for the China piriformis syndrome market in 2035 is expected to reach $0.04 Million. Read More

What was the market valuation for the China piriformis syndrome market in 2024?

The overall market valuation for the China piriformis syndrome market was $0.02 Million in 2024. Read More

What is the expected CAGR for the China piriformis syndrome market during the forecast period 2025 - 2035?

The expected CAGR for the China piriformis syndrome market during the forecast period 2025 - 2035 is 5.86%. Read More

Which companies are key players in the China piriformis syndrome market?

Key players in the China piriformis syndrome market include Medtronic, Johnson & Johnson, Stryker, Boston Scientific, Abbott Laboratories, B. Braun Melsungen AG, Zimmer Biomet, and Smith & Nephew. Read More

What are the main causes of piriformis syndrome as per market segmentation?

The main causes of piriformis syndrome include trauma, spasms, overuse injury, and others, with respective valuations ranging from $0.004 Million to $0.015 Million. Read More

What diagnostic tests are utilized in the China piriformis syndrome market?

Diagnostic tests utilized include MRI, CT, X-rays, neurophysiologic testing, EMG, Beatty test, and FAIR test, with valuations from $0.001 Million to $0.01 Million. Read More

What treatment options are available for piriformis syndrome in the market?

Treatment options available include medication, physical therapy, acupuncture, prolotherapy, OMT, surgery, and others, with valuations from $0.0005 Million to $0.015 Million. Read More

What distribution channels are prominent in the China piriformis syndrome market?

Prominent distribution channels include e-commerce, retail pharmacies, and others, with valuations ranging from $0.004 Million to $0.016 Million. Read More

Who are the primary end-users of piriformis syndrome treatments?

Primary end-users of piriformis syndrome treatments include hospitals & clinics, diagnostic centers, and others, with valuations from $0.003 Million to $0.02 Million. Read More

How does the market for piriformis syndrome in China compare to other regions?

While specific comparisons to other regions are not provided, the China piriformis syndrome market is characterized by a projected growth trajectory and key players that indicate a developing landscape. Read More

China Piriformis Syndrome Market

China Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.86%

2024 Market Size

$ 0.02 Million

2035 Market Size

$ 0.04 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/55055-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Cause (USD Million)
  1. 4.1.1 Trauma
  2. 4.1.2 Spasms
  3. 4.1.3 Overuse injury
  4. 4.1.4 Others
2. 4.2 Medical Device, BY Diagnostic Test (USD Million)
  1. 4.2.1 Magnetic Resonance Imaging (MRI)
  2. 4.2.2 Computed Tomography (CT)
  3. 4.2.3 X-rays
  4. 4.2.4 Neurophysiologic Testing
  5. 4.2.5 Electromyography (EMG)
  6. 4.2.6 Beatty Test
  7. 4.2.7 FAIR (Flexion, adduction, and Internal Rotation) Test
  8. 4.2.8 Others
3. 4.3 Medical Device, BY Treatment (USD Million)
  1. 4.3.1 Medication
  2. 4.3.2 Physical Therapy
  3. 4.3.3 Acupuncture
  4. 4.3.4 Prolotherapy
  5. 4.3.5 Osteopathic Manipulative Treatment (OMT)
  6. 4.3.6 Surgery
  7. 4.3.7 Others
4. 4.4 Medical Device, BY Distribution Channel (USD Million)
  1. 4.4.1 E-Commerce
  2. 4.4.2 Retail Pharmacies
  3. 4.4.3 Others
5. 4.5 Medical Device, BY End-User (USD Million)
  1. 4.5.1 Hospitals & Clinics
  2. 4.5.2 Diagnostic Centers
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Stryker (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Abbott Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Zimmer Biomet (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Smith & Nephew (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY CAUSE
3. 6.3 CHINA MARKET ANALYSIS BY DIAGNOSTIC TEST
4. 6.4 CHINA MARKET ANALYSIS BY TREATMENT
5. 6.5 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 CHINA MARKET ANALYSIS BY END-USER
7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
13. 6.13 MEDICAL DEVICE, BY CAUSE, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY CAUSE, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY DIAGNOSTIC TEST, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY DIAGNOSTIC TEST, 2024 TO 2035 (USD Million)
17. 6.17 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
18. 6.18 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
19. 6.19 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
20. 6.20 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
21. 6.21 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
22. 6.22 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY CAUSE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSTIC TEST, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Piriformis Syndrome Market Segmentation

China Piriformis Syndrome Market By Cause (USD Million, 2025-2035)

Trauma
Spasms
Overuse injury
Others

China Piriformis Syndrome Market By Diagnostic Test (USD Million, 2025-2035)

Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
X-rays
Neurophysiologic Testing
Electromyography (EMG)
Beatty Test
FAIR (Flexion, adduction, and Internal Rotation) Test
Others

China Piriformis Syndrome Market By Treatment (USD Million, 2025-2035)

Medication
Physical Therapy
Acupuncture
Prolotherapy
Osteopathic Manipulative Treatment (OMT)
Surgery
Others

China Piriformis Syndrome Market By Distribution Channel (USD Million, 2025-2035)

E-Commerce
Retail Pharmacies
Others

China Piriformis Syndrome Market By End-User (USD Million, 2025-2035)

Hospitals & Clinics
Diagnostic Centers
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”